TrialPloS one2020

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.

Lena Stockhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.